<DOC>
	<DOCNO>NCT00047710</DOCNO>
	<brief_summary>The goal clinical research study find high safe dose drug Bevacizumab give combination chemoradiation treatment pancreatic cancer . The effect combination treatment tumor also study .</brief_summary>
	<brief_title>Study Combined RHUMAB VEGF Capecitabine-based Chemoradiation Patients With Locally Advanced Pancreatic Cancer</brief_title>
	<detailed_description>This study administer 50.4 Gy radiation unresectable pancreatic cancer concurrent capecitabine experimental drug , Bevacizumab . The drug antiangiogenic agent ( kill tumor blood vessel ) show preclinical model enhance antitumor effect radiation chemotherapy .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Cytology histologic proof adenocarcinoma pancreatic head , body tail prior treatment . Patients nonmetastatic , unresectable , disease eligible . Patients regional nodal disease eligible . Karnofsky performance status &gt; /=70 . No upper age restriction . Absolute granulocyte count &gt; 1,500 cells/mm3 platelet count least 100,000 cells/mm3 . Serum bilirubin less 5mg/dl prior start therapy adequate biliary decompression . Adequate bilateral renal function . Serum creatinine &lt; 1.5 mg/dl . Adequate liver function ; Alanine aminotransferase ( ALT ) /aspartate aminotransferase ( AST ) &lt; /=5 time upper limit normal . Sexually active men must practice contraception study . Patients must sign studyspecific consent form . History evidence upon physical examination CNS disease . Active infection require parenteral antibiotic Day 0 . Major surgical procedure , open biopsy , significant traumatic injury within 28 day prior Day 0 , anticipation need major surgical procedure course study . Current recent use fulldose oral parenteral anticoagulant thrombolytic agent . Chronic , daily treatment aspirin nonsteroidal antiinflammatory medication . Pregnancy lactation . Proteinuria baseline impairment renal function . Serious , nonhealing wound , ulcer , bone fracture . Evidence bleed diathesis coagulopathy Clinically significant cardiovascular disease , congestive heart failure , serous cardiac arrhythmia require medication , significant peripheral vascular disease within 1 year prior Day 0 . History aneurysm , stroke , transient ischemic attack , arteriovenous malformation . Serous concomitant medical psychiatric disorder . Cohort receive Capecitabine</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>pancreatic cancer</keyword>
	<keyword>pancreas cancer</keyword>
	<keyword>pancreas</keyword>
</DOC>